Rui Hu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 5
- Epigenetics and DNA Methylation 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Haibo Xiao (6 shared papers)Bingqian Zhou (3 shared papers)Zheyi Chen (3 shared papers)Lisong Shen (3 shared papers)Shiyu Chen (3 shared papers)Yingxia Zheng (3 shared papers)Yanhui Ma (2 shared papers)Guohua Xie (2 shared papers)
- Journals
- Heliyon (2 papers)Biomedicine & Pharmacotherapy (2 papers)Cell Death Discovery (2 papers)Journal of Orthopaedic Surgery and Research (1 paper)Environmental Toxicology (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Rui Hu
42 papers receiving 936 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 230
- Immunology 196
- Oncology 201
- Molecular Biology 442
- Pulmonary and Respiratory Medicine 123
Countries citing papers authored by Rui Hu
This map shows the geographic impact of Rui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Hu more than expected).
Fields of papers citing papers by Rui Hu
This network shows the impact of papers produced by Rui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Hu. The network helps show where Rui Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Rui Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 300 | |
| 2 | miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN. | 2015 | 45 |
| 3 | 2020 | 44 | |
| 4 | 2013 | 40 | |
| 5 | 2022 | 36 | |
| 6 | 2020 | 36 | |
| 7 | 2023 | 33 | |
| 8 | 2019 | 32 | |
| 9 | 2022 | 30 | |
| 10 | 2023 | 29 | |
| 11 | 2017 | 29 | |
| 12 | 2022 | 26 | |
| 13 | 2020 | 26 | |
| 14 | 2014 | 25 | |
| 15 | 2015 | 19 | |
| 16 | 2021 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2023 | 14 | |
| 19 | 2020 | 11 | |
| 20 | 2023 | 11 |
About Rui Hu
Rui Hu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 45 papers that have together received 942 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Ferroptosis and cancer prognosis (6 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers), Epigenetics and DNA Methylation (4 papers), Immune Cell Function and Interaction (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (230 citations), Immunology (196 citations), Oncology (201 citations), Molecular Biology (442 citations) and Pulmonary and Respiratory Medicine (123 citations). Rui Hu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Haibo Xiao, Bingqian Zhou, Zheyi Chen, Lisong Shen, Shiyu Chen, Yingxia Zheng, Yanhui Ma, Guohua Xie, Han Li and Junyao Yang. Their work appears in journals such as Heliyon, Biomedicine & Pharmacotherapy, Cell Death Discovery, Journal of Orthopaedic Surgery and Research and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.